New Era in the Management of Cardio-Renal-Metabolic Diseases

Saudi Heart Association
3/31/21, 12:30 AM
Asia/Istambul GMT+3

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Khalid Al Faraldy

Welcoming & Introduction, Evolving evidence based clinical recommendations in T2D management, An abundance of SGLT2-i clinical evidence "EMPEROR-Reduced: a late breaking trial on Empagliflozin CV & renal outcomes in HF", Q & A, Closing

Inglês

 

Speakers

Abdulqawi Almansari, Ayman Abdelhady

 

Link to the Event

Banner to the Event

New Era in the Management of Cardio-Renal-Metabolic Diseases